Independent fund research. Built on SEC filings.

How we research funds

ETF · Allocation / Balanced · Grayscale

McElhenny Sheffield Managed Risk ETF (MSMR)

Ticker MSMR · Since 2021-11-16 · · Holdings as of Jul 31, 2026

Expense ratio
1.06%$106/yr per $10k
1-yr return
+15.8%as of Dec 2025
Net assets
$182.4Mall share classes
Holdings
5

Bottom line

Is MSMR a good fund? The bottom line

MSMR is an actively managed allocation / balanced ETF from Grayscale.

Its expense ratio is 1.06% — about $106 a year on every $10,000 invested, more expensive than 64% of allocation / balanced funds we track.

It returned +15.8% over one year (as of Dec 31, 2025, per its prospectus).

With $182 million in net assets and 5 holdings, its largest position is iShares 0-3 Month Treasury Bon (39.5%) and the top 10 make up 100.1% of the portfolio.

What to watch

  • Concentrated: top 10 holdings are 100.1% of assets
  • High turnover (598% a year) can mean more taxable distributions

Updated Nov 19, 2026

What MSMR invests in

The McElhenny Sheffield Managed Risk ETF (the Fund) seeks capital appreciation while managing downside risk.

The Fund is an actively managed exchange-traded fund (ETF) that employs proprietary trend-based and sector rotation strategies developed by McElhenny Sheffield Capital Management, LLC, the Funds investment sub-adviser (the Sub-Adviser). The Fund invests in shares of other ETFs (Underlying Investments) based on a rules-based process managed by the Sub-Adviser that reflects a blend of the Sub-Advisers trend-based and sector rotation strategies, as described below. Under normal market conditions, the Fund invests approximately 100% of its assets in the Underlying Investments. The Fund may take temporary defensive positions when the Sub-Adviser believes that current market, economic, political or other conditions are unsuitable and would impair the pursuit of the Funds investment objective. The Sub-Adviser expects to generally allocate approximately 50% of the Funds assets to each of the…

From the fund's prospectus (filed Feb 26, 2026).

MSMR performance

Fund calendar-year total returns, 2022–2025 2022: −11.9%; 2023: +18.5%; 2024: +21.6%; 2025: +15.8% −11.9% 2022 +18.5% 2023 +21.6% 2024 +15.8% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
MSMR+15.8%——
Allocation / Balanced median+11.0%+5.7%+6.7%

Source: Fund prospectus, as of Dec 31, 2025

Full MSMR performance history →

What MSMR costs

On a $10,000 investment, MSMR's 1.06% expense ratio costs about $106 a year. The prospectus estimates $1,294 in total costs over 10 years (assuming 5% annual returns). The median allocation / balanced fund charges 0.91%.

See the full MSMR fee table →

MSMR top 10 holdings

#Holding% of fund
1iShares 0-3 Month Treasury Bon SGOV39.45%
2First American Treasury Obliga20.00%
3iShares U.S. Pharmaceuticals E IHE15.59%
4iShares Russell 2000 ETF IWM14.99%
5SPDR Gold MiniShares Trust GLDM10.04%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 100.1% of the fund. See all top 25 holdings and asset mix →

Alternatives to MSMR

More funds like MSMR →

MSMR FAQ

What is the expense ratio of MSMR?
MSMR's expense ratio is 1.06%, which works out to about $106 a year for every $10,000 invested. The prospectus estimates total costs of $1,294 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MSMR a good investment?
It depends on your goals, but the data points to: concentrated: top 10 holdings are 100.1% of assets; high turnover (598% a year) can mean more taxable distributions. This is general information, not personalized advice.
What does MSMR hold?
MSMR's largest holdings are iShares 0-3 Month Treasury Bon (39.5%), First American Treasury Obliga (20.0%), iShares U.S. Pharmaceuticals E (15.6%), iShares Russell 2000 ETF (15.0%), SPDR Gold MiniShares Trust (10.0%). It holds 5 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
Who manages MSMR?
MSMR is offered by Grayscale through ETF Series Solutions.